Department of Immune Regulation

20  articles.  
* There may be some overlapped articles listed due to the difference of format.

  1. Huihui Xiang, Rika Kasajima, Koichi Azuma, Tomoyuki Tagami, Asami Hagiwara, Yoshiro Nakahara, Haruhiro Saito, Yuka Igarashi, Feifei Wei, Tatsuma Ban, Mitsuyo Yoshihara, Yoshiyasu Nakamura, Shinya Sato, Shiro Koizume, Tomohiko Tamura, Tetsuro Sasada, Yohei Miyagi.: Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma Frontiers in Immunology. 2024.12; 13 (15): 1361992. ( PubMed , DOI )

  2. Okano T, Ashida H, Komatsu N, Tsukasaki M, Iida T, Iwasawa M, Takahashi Y, Takeuchi Y, Iwata T, Sasai M, Yamamoto M, Takayanagi H, Suzuki T: Caspase-11 mediated inflammasome activation in macrophages by systemic infection of #IA. actinomycetemcomitans#IR exacerbates arthritis International journal of oral science. 2024.08; 16 (1): 54. ( PubMed , DOI )

  3. Nam Cong-Nhat Huynh, Rui Ling, Komagamine Masatsugu, Shi Tianshu, Tsukasaki Masayuki, Matsuda Kotaro, Okamoto Kazuo, Asano Tatsuo, Muro Ryunosuke, Pluemsakunthai Warunee, Kollias George, Kaneko Yuko, Takeuchi Tsutomu, Tanaka Sakae, Komatsu Noriko, Takayanagi Hiroshi: 自己免疫性関節炎の薬物標的としてのオンコスタチンM駆動マクロファージ-線維芽細胞回路(Oncostatin M-Driven macrophage-fibroblast circuits as a drug target in autoimmune arthritis) Inflammation and Regeneration. 2024.07; 44 s41232-024. ( ichushi )

  4. The neutrophil-osteogenic cell axis promotes bone destruction in periodontitis. 2024.02; 16 (1): 18. ( PubMed , DOI )

  1. Effect of JAK inhibitors on the three forms of bone damage in autoimmune arthritis: joint erosion, periarticular osteopenia, and systemic bone loss. 2023.09; 43 (1): 44. ( PubMed , DOI )

  2. Komagamine Masatsugu, Komatsu Noriko, Ling Rui, Okamoto Kazuo, Tianshu Shi, Matsuda Kotaro, Takeuchi Tsutomu, Kaneko Yuko, Takayanagi Hiroshi: 自己免疫性関節炎においてJAK阻害剤が3種類の骨損傷病変に及ぼす影響　関節びらん、関節周囲の骨減少、全身の骨喪失(Effect of JAK inhibitors on the three forms of bone damage in autoimmune arthritis: joint erosion, periarticular osteopenia, and systemic bone loss) Inflammation and Regeneration. 2023.09; 43 1 of 14-14 of 14. ( ichushi )

  1. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. 2022.07; 18 (7): 415-429. ( PubMed , DOI )

  2. Masayuki Tsukasaki, Noriko Komatsu, Takako Negishi-Koga, Nam Cong-Nhat Huynh, Ryunosuke Muro, Yutaro Ando, Yuka Seki, Asuka Terashima, Warunee Pluemsakunthai, Takeshi Nitta, Takashi Nakamura, Tomoki Nakashima, Shinsuke Ohba, Haruhiko Akiyama, Kazuo Okamoto, Roland Baron, Hiroshi Takayanagi: Periosteal stem cells control growth plate stem cells during postnatal skeletal growth. Nat Commun. 2022.07; 13 (1): 4166. ( PubMed , DOI )

  1. Noriko Komatsu, Stephanie Win, Minglu Yan, Nam Cong-Nhat Huynh, Shinichiro Sawa, Masayuki Tsukasaki, Asuka Terashima, Warunee Pluemsakunthai, George Kollias, Tomoki Nakashima, Hiroshi Takayanagi: Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis. J Clin Invest. 2021.03; 131 (6): ( PubMed , DOI )

  1. Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution. 2020.12; 2 (12): 1382-1390. ( PubMed , DOI )

  2. OPG Production Matters Where It Happened. 2020.09; 32 (10): 108124. ( PubMed , DOI )

  3. Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells. 2020.08; 58 102913. ( PubMed , DOI )

  4. T cells in the regulation of bone metabolism 2020.06; 12-19.

  1. Immune-bone interplay in the structural damage in rheumatoid arthritis. 2018.10; 194 (1): 1-8. ( PubMed , DOI )

  2. Masayuki Tsukasaki, Noriko Komatsu, Kazuki Nagashima, Takeshi Nitta, Warunee Pluemsakunthai, Chisa Shukunami, Yoichiro Iwakura, Tomoki Nakashima, Kazuo Okamoto, Hiroshi Takayanagi: Host defense against oral microbiota by bone-damaging T cells. Nat Commun. 2018.02; 9 (1): 701. ( PubMed , DOI )

  1. Kazuo Okamoto, Tomoki Nakashima, Masahiro Shinohara, Takako Negishi-Koga, Noriko Komatsu, Asuka Terashima, Shinichiro Sawa, Takeshi Nitta, Hiroshi Takayanagi: Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. Physiol. Rev.. 2017.10; 97 (4): 1295-1349. ( PubMed , DOI )

  2. LOX Fails to Substitute for RANKL in Osteoclastogenesis. 2017.03; 32 (3): 434-439. ( PubMed , DOI )

  1. Nam Cong-Nhat Huynh, Rui Ling, Masatsugu Komagamine, Tianshu Shi, Masayuki Tsukasaki, Kotaro Matsuda, Kazuo Okamoto, Tatsuo Asano, Ryunosuke Muro, Warunee Pluemsakunthai, George Kollias, Yuko Kaneko, Tsutomu Takeuchi, Sakae Tanaka, Noriko Komatsu, Hiroshi Takayanagi: Oncostatin M-driven macrophage-fibroblast circuits as a drug target in autoimmune arthritis Inflammation and Regeneration. 2024.07; 44 (1): ( PubMed , DOI )

  1. Minglu Yan, Masayuki Tsukasaki, Ryunosuke Muro, Yutaro Ando, Kazutaka Nakamura, Noriko Komatsu, Takeshi Nitta, Tadashi Okamura, Kazuo Okamoto, Hiroshi Takayanagi: Identification of an intronic enhancer regulating RANKL expression in osteocytic cells Bone Research. 2023.08; 11 (1): ( DOI )

  1. Minglu Yan, Noriko Komatsu, Ryunosuke Muro, Nam Cong-Nhat Huynh, Yoshihiko Tomofuji, Yukinori Okada, Hiroshi I. Suzuki, Hiroyuki Takaba, Riko Kitazawa, Sohei Kitazawa, Warunee Pluemsakunthai, Yuichi Mitsui, Takashi Satoh, Tadashi Okamura, Takeshi Nitta, Sin-Hyeog Im, Chan Johng Kim, George Kollias, Sakae Tanaka, Kazuo Okamoto, Masayuki Tsukasaki, Hiroshi Takayanagi: ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts Nature Immunology. 2022.09; 23 (9): 1330-+. ( PubMed , DOI )

To the head of this page.▲